Search Within

Boglarka Gyurkocza

Formats
  1. Meeting Abstract (91)
  2. Journal Article (39)
  3. Research Letter (7)
  4. Review (1)
Groups
  1. Bone Marrow Transplant (138)
  2. Center for Hematologic Malignancies (138)
  3. Department of Medicine (138)
  4. Hematologic Malignancies, Division of (138)
  5. Survivorship Research (138)
  6. CTCR Scholars (104)

More Groups

People
  1. Sergio Giralt (117)
  2. Miguel-Angel Perales (97)
  3. Roni Tamari (80)
  4. Brian Shaffer (79)
  5. Esperanza Papadopoulos (77)
  6. Sean Devlin (72)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (10)
  6. 2020 (21)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (40)
  2. Blood (40)
  3. Bone Marrow Transplantation (13)
  4. Blood Advances (9)
  5. Transplantation and Cellular Therapy (9)
  6. Clinical Lymphoma, Myeloma and Leukemia (4)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. American Society of Hematology (49)
  3. Nature Publishing Group (13)
  4. American Society of Clinical Oncology (4)
  5. John Wiley & Sons, Inc. (3)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
    Journal Article

    Wudhikarn, K.; King, A. C.; Geyer, M. B.; Roshal, M.; Bernal, Y.; Gyurkocza, B.; Perales, M. A.; Park, J. H.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Clinical experience in the randomized phase 3 Sierra Trial: Anti-CD45 iodine ((131)I) apamistamab [Iomab-B] conditioning enables hematopoietic cell transplantation with successful engraftment and acceptable safety in patients with active, relapsed/refractory AML not responding to targeted therapies
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Litzow, M. R.; Koshy, N. V.; Stiff, P.; Abboud, C. Sr; Tomlinson, B.; Abhyankar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of "Donors for all"
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in allograft recipients
    Journal Article

    Tamari, R.; Brown, S.; Devlin, S. M.; Kosuri, S.; Maloy, M. A.; Ponce, D. M.; Sauter, C.; Shaffer, B.; Dahi, P.; Young, J. W.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save